MediWound Ltd.
MDWD
$17.40
$0.070.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 20.22M | 19.72M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 20.22M | 19.72M | |
| Cost of Revenue | -- | -- | 17.59M | 17.27M | |
| Gross Profit | -- | -- | 2.63M | 2.45M | |
| SG&A Expenses | -- | -- | 13.14M | 11.93M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 18.00K | 224.00K | |
| Total Operating Expenses | -- | -- | 39.62M | 37.12M | |
| Operating Income | -- | -- | -19.40M | -17.40M | |
| Income Before Tax | -- | -- | -30.16M | -27.90M | |
| Income Tax Expenses | -- | -- | 61.00K | 163.00K | |
| Earnings from Continuing Operations | -- | -- | -30.22 | -28.06 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -30.22M | -28.06M | |
| EBIT | -- | -- | -19.40M | -17.40M | |
| EBITDA | -- | -- | -18.13M | -16.13M | |
| EPS Basic | -- | -- | -3.07 | -2.90 | |
| Normalized Basic EPS | -- | -- | -0.65 | -1.11 | |
| EPS Diluted | -- | -- | -3.07 | -2.90 | |
| Normalized Diluted EPS | -- | -- | -0.65 | -1.11 | |
| Average Basic Shares Outstanding | -- | -- | 39.82M | 38.24M | |
| Average Diluted Shares Outstanding | -- | -- | 39.82M | 38.24M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |